Article

Mitopure™ will make its debut in Timeline consumer product

Amazentis announces the launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos. Timeline, a revolutionary nutrition product to promote healthy aging, will be available in the United States in the first half of 2020.

Amazentis announces the debut of Timeline, a next-generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World Economic Forum in Davos, Switzerland. Given the increase in the aging population globally — according to a 2019 Deutsche Bank study, there are more people on Earth older than sixty-five than younger than five for the first time — consumers must take proactive measures to maintain a high quality of life, for as long as they live.

Timeline contains the proprietary nutrient Mitopure™, a highly pure form of Urolithin A. After a decade of rigorous research by leading scientists around the world, Mitopure has been shown to help counter age-associated cellular and muscular decline by revitalizing the mitochondria, the powerplants of our cells.

“After a decade of research and trials to perfect Mitopure, we’re giving consumers access to a product that improves their muscle health by targeting aging mitochondria,” said Amazentis CEO and Co-Founder, Chris Rinsch. “For years, consumers have been searching for a solution to maintain muscle health as they age; Timeline provides a new way to proactively take control of cellular health early on, which directly impacts the aging process.” added Amazentis Co-Founder and Chairman Patrick Aebischer.

The World Economic Forum engages societal leaders to shape global, regional, and industry agendas. As part of the Forum, there will be a panel discussion on January 23rd at 15:00 CET at the House of Switzerland, focusing on the food and nutrition industry innovations. During the conversation, Rinsch will share the health benefits of Timeline and Mitopure with the audience. The panel will be moderated by CNN Money Switzerland Anchor Anna Maria Montero and include:

  • Nestlé Global Chairman of the Board, Paul Bulcke
  • École Polytechnique Fédérale de Lausanne (EPFL) President, Martin Vetterli
  • 3 Star Michelin Chef, Hôtel de Ville de Crissier, Franck Giovannini
  • Amazentis CEO and Co-Founder, Chris Rinsch
[@portabletext/react] Unknown block type "block", specify a component for it in the `components.types` prop
[@portabletext/react] Unknown block type "block", specify a component for it in the `components.types` prop

About Timeline

[@portabletext/react] Unknown block type "block", specify a component for it in the `components.types` prop

Knowledge is power

Sign up to our newsletter

Knowledge is power
Sign up to our newsletter

Shop

InstagramFacebookYouTube

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. References: *Nutrition studies: 500mg Mitopure® have been shown to (1) induce gene expression related to mitochondria function and metabolism and (2) increase the strength of the hamstring leg muscle in measures of knee extension and flexion in overweight 40-65 year olds. Data from two randomized double-blind placebo-controlled human clinical trials. **Nutrition NOURISH Study: 500mg Mitopure® have been shown to deliver at least 6 times higher Urolithin A plasma levels over 24 hours (area under the curve) than 8 ounces (240ml) of pomegranate juice in a randomized human clinical trial.